893|730|Public
25|$|A {{computed}} tomography or CT scan {{can also provide}} a mode {{detailed analysis of the}} lungs, and can reveal cavitation due to concomitant <b>mycobacterial</b> <b>infection.</b>|$|E
25|$|Thalidomide {{has been}} {{approved}} by the FDA for ENL and MM in combination with dexamethasone. EMA has also approved it to treat MM in combination with prednisone and/or melphalan. Orphan indications by the FDA include graft-versus-host disease, <b>mycobacterial</b> <b>infection,</b> recurrent aphthous ulcers, severe recurrent aphthous stomatitis, primary brain malignancies, HIV-associated wasting syndrome, Crohn's disease, Kaposi’s sarcoma, myelodysplastic syndrome and hematopoietic stem cell transplantantion.|$|E
25|$|The {{infection}} {{occurs in}} well-defined areas throughout the world, mostly tropical areas — {{in several areas}} in Australia, in Uganda, in several countries in West Africa, in Central and South America, in southeast Asia and New Guinea. It is steadily rising as a serious disease, especially in West Africa and underdeveloped countries, where it is the third leading cause of <b>mycobacterial</b> <b>infection</b> in healthy people, after tuberculosis and leprosy.|$|E
40|$|Nine {{patients}} exhibiting {{the characteristic}} clinical patterns in cutaneous atypical <b>mycobacterial</b> <b>infections</b> are presented. The verrucous plaque, sporotrichoid, ulcerated abscess, and scrophulous presentations are illustrated. The history, clinical appearance {{and treatment of}} cutaneous ‘atypical’ <b>mycobacterial</b> <b>infections</b> are reviewed...|$|R
40|$|Nontuberculous <b>mycobacterial</b> <b>infections</b> {{can cause}} {{destructive}} tenosynovitis of the hand. We report on {{and discuss the}} clinical course and distinctive radiologic findings of two patients with hand tenosynovitis secondary to M. marinum and intracellulare infection, which {{are different from those}} of the nontuberculous <b>mycobacterial</b> <b>infections</b> reported in the previous literature...|$|R
50|$|Small {{studies have}} also {{examined}} its use as salvage therapy for non-tuberculous <b>mycobacterial</b> <b>infections.</b>|$|R
25|$|In {{areas where}} TB is highly endemic, {{it is not}} unusual to {{encounter}} patient with a fever, but in whom no source of infection is found. The physician may then, after extensive investigation has excluded all other diseases, resort to a trial of TB treatment. The regimen used is HEZ for a minimum of three weeks; RMP and STM are omitted from the regimen because they are broad spectrum antibiotics, whereas the other three first-line drugs treat only <b>mycobacterial</b> <b>infection.</b> Resolution of the fever after three weeks of treatment is good evidence for occult TB and the patient should then be changed to conventional TB treatment (2HREZ/4HR). If the fever does not resolve after three weeks of treatment then it is reasonable to conclude that the patient has another cause for his fever.|$|E
2500|$|Complicated silicosis: Silicosis {{can become}} [...] "complicated" [...] by the {{development}} of severe scarring (progressive massive fibrosis, or also known as conglomerate silicosis), where the small nodules gradually become confluent, reaching a size of 1nbsp&cm or greater. [...] PMF is associated with more severe symptoms and respiratory impairment than simple disease. Silicosis can also be complicated by other lung disease, such as tuberculosis, non-tuberculous <b>mycobacterial</b> <b>infection,</b> and fungal infection, certain autoimmune diseases, and lung cancer. Complicated silicosis is more common with accelerated silicosis than with the chronic variety.|$|E
50|$|Defects in IFNGR2 are a {{cause of}} {{autosomal}} recessive mendelian susceptibility to mycobacterial disease (MSMD), also known as familial disseminated atypical <b>mycobacterial</b> <b>infection.</b>|$|E
50|$|Rifampicin is {{also used}} to treat non-tuberculous <b>mycobacterial</b> <b>infections</b> {{including}} leprosy (Hansen's disease) and Mycobacterium kansasii.|$|R
50|$|IFNGR1 {{deficiency}} {{is associated}} with the increased susceptibility to certain infectious diseases in patients, especially <b>mycobacterial</b> <b>infections.</b>|$|R
50|$|As {{corticosteroids}} are immunosuppressive, loteprednol is contraindicated {{in patients}} with viral, fungal or <b>mycobacterial</b> <b>infections</b> of the eye.|$|R
50|$|A {{computed}} tomography or CT scan {{can also provide}} a mode {{detailed analysis of the}} lungs, and can reveal cavitation due to concomitant <b>mycobacterial</b> <b>infection.</b>|$|E
50|$|Mendelian {{susceptibility}} to mycobacterial disease, also called familial disseminated atypical <b>mycobacterial</b> <b>infection,</b> {{is a rare}} genetic disease characterized by {{susceptibility to}} mycobacteria and Salmonella infection outside of the intestinal tract.|$|E
5000|$|... #Caption: A) Neck {{and chest}} of a 53-year-old woman 14 days after {{fractionated}} CO2 laser resurfacing, showing Nontuberculous <b>Mycobacterial</b> <b>infection</b> B) Neck {{of the patient}} after 5 months of multidrug therapy and pulsed dye laser treatment.|$|E
5000|$|Infectious {{diseases}} and immunopathogenesis (including Q Fever, melioidosis, streptococcal <b>infections,</b> <b>mycobacterial</b> <b>infections,</b> helminth infections, toxoplasmosis, intersections between communicable and non-communicable diseases). Led by Professor Natkunam Ketheesan, Professor Alex Loukas, Dr Brenda Govan, and Professor Nicholas Smith.|$|R
40|$|The {{control of}} chronic {{bacterial}} diseases with high prevalence {{in areas of}} endemicity would strongly benefit from availability of postexposure vaccines. The development of these vaccines against <b>mycobacterial</b> <b>infections,</b> such as (para) tuberculosis, is hampered by lack of experience in natural hosts. Paratuberculosis in cattle is both a mycobacterial disease of worldwide importance and a natural host model for <b>mycobacterial</b> <b>infections</b> in general. The present study showed beneficial effects of therapeutic heat shock protein 70 (Hsp 70) vaccination in cattle with naturally acquired chronic infection with Mycobacterium avium subsp. paratuberculosis. Vaccination-induced protection was associated with antibody responses, rather than with induction of specific T helper 1 cells. Targeted therapeutic postexposure vaccination complementary to selective use of antibiotics could be an effective approach for control of chronic <b>mycobacterial</b> <b>infections.</b> W. S. {{was supported by a}} grant from MSD Animal Health, Boxmeer, the Netherland. [URL]...|$|R
40|$|Problem statement: To {{demonstrate}} {{the presentation of}} atypical <b>mycobacterial</b> postsurgical&# 13; <b>infections</b> and their management. Approach: Single patient case report. Results: Successful&# 13; management of atypical <b>mycobacterial</b> post operative <b>infection</b> with preservation of instrumented&# 13; hardware posterior pedicle screw fixation and interbody cages. Conclusion: This report suggests that&# 13; these atypical <b>mycobacterial</b> <b>infections</b> can be eradicated with successful outcomes with preservation&# 13; of spinal instrumentation...|$|R
5000|$|... #Caption: Granulation tissue with {{a poorly}} formed {{granuloma}} {{to the left}} of centre. Within this area there is a multinucleate giant cell of the Langhans type. The patient had a healing <b>mycobacterial</b> <b>infection</b> of the skin (M. ulcerans infection).|$|E
50|$|In Australia, an {{alternative}} therapy salon {{is being investigated}} by the Health Department after several clients developed skin abscesses on the calves, buttocks, thighs, abdomen, shoulders, face and neck from the treatment, with one patient also developing a <b>mycobacterial</b> <b>infection.</b>|$|E
50|$|The more {{commonly}} used term is nontuberculous mycobacteria (NTM) infection, or non-tuberculous <b>mycobacterial</b> <b>infection</b> (NMI). There {{is no evidence that}} a person's reluctance to spit has any causal role in NTM infection, the chief reason for the term having been applied to older women presenting with the condition.|$|E
5000|$|<b>Mycobacterial</b> <b>infections,</b> {{including}} as a second-line {{agent for}} active tuberculosis. It {{is also used}} for infections by Mycobacterium avium, M. abcessus, M. chelonae, and M. fortuitum.|$|R
40|$|Abstract Background In {{areas where}} both {{tuberculosis}} (TB) and nontuberculous mycobacteria (NTM) are prevalent, descriptive {{studies of the}} clinical features of individual mycobacteria are needed to inform clinical triage. Methods We queried the University of Virginia Clinical Data Repository for all <b>mycobacterial</b> <b>infections</b> from 2001 - 2009. Results Of 494 <b>mycobacterial</b> <b>infections</b> in 467 patients there were 22 species. Patients with pulmonary Tb {{were more likely to}} be reported as immigrants (p M. kansasii, M. xenopi, and M. fortuitum were more likely than MAC to have cavities. There were at least 83 patients that met criteria for NTM lung disease and these were caused by 9 species. M. abscessus infection was associated with cystic fibrosis and M. xenopi infection was associated with male gender. Conclusions In our center <b>mycobacterial</b> <b>infections</b> were common and of diverse species. Immigrant status, cavities, and effusion were associated with TB vs. NTM. </p...|$|R
50|$|Liposomal {{amikacin}} for inhalation {{is currently}} in late stage clinical trials {{for the treatment of}} respiratory diseases, such as cystic fibrosis, Pseudomonas aeruginosa, non-tubercular <b>mycobacterial</b> <b>infections</b> and bronchiectasis.|$|R
50|$|The {{nature of}} the host-pathogen {{interaction}} between humans and M. tuberculosis is considered to have a genetic component. A group of rare disorders called Mendelian susceptibility to mycobacterial diseases was observed in a subset of individuals {{with a genetic defect}} that results in increased susceptibility to <b>mycobacterial</b> <b>infection.</b>|$|E
50|$|Thalidomide {{has been}} {{approved}} by the FDA for ENL and MM in combination with dexamethasone. EMA has also approved it to treat MM in combination with prednisone and/or melphalan. Orphan indications by the FDA include graft-versus-host disease, <b>mycobacterial</b> <b>infection,</b> recurrent aphthous ulcers, severe recurrent aphthous stomatitis, primary brain malignancies, HIV-associated wasting syndrome, Crohn's disease, Kaposi’s sarcoma, myelodysplastic syndrome and hematopoietic stem cell transplantantion.|$|E
50|$|The {{infection}} {{occurs in}} well-defined areas throughout the world, mostly tropical areas — {{in several areas}} in Australia, in Uganda, in several countries in West Africa, in Central and South America, in southeast Asia and New Guinea. It is steadily rising as a serious disease, especially in West Africa and underdeveloped countries, where it is the third leading cause of <b>mycobacterial</b> <b>infection</b> in healthy people, after tuberculosis and leprosy.|$|E
40|$|We {{report a}} patient with {{psoriasis}} who developed Mycobacterium marinum (M. marinum) infection {{after seven years of}} treatment with adalimumab, a human anti-TNF (tumor necrosis factor) monoclonal antibody. TNF is a pro-inflammatory cytokine that plays {{a central role in the}} pathogenesis of psoriasis and a number of other immune-mediated inflammatory diseases. TNF plays an important role in granuloma formation and host defense against <b>mycobacterial</b> <b>infections.</b> Several cases of atypical <b>mycobacterial</b> <b>infections</b> in patients on TNF inhibitors have been reported. To our knowledge, this is the second reported case of M. marinum infection in a patient on adalimumab for the treatment of psoriasis...|$|R
40|$|Mycobacterium xenopi is a water-related {{mycobacterium}} {{with low}} pathogenicity in humans. Little {{is known about}} the association between anti-tumour necrosis factor (TNF) a and non-tuberculous <b>mycobacterial</b> <b>infections.</b> The case history is presented of fatal M xenopi infection in a patient receiving anti-TNFa treatment. M ycobacterium xenopi is a water-related mycobacterium with low pathogenicity in humans. Although the association between anti-tumour necrosis factor (TNF) a treatment and Mycobacterium tuberculosis is well known, 1 2 relatively little {{is known about the}} association with non-tuberculous <b>mycobacterial</b> <b>infections.</b> We present the first case of fatal M xenopi infection in a patient receiving anti-TNFa treatment...|$|R
40|$|Upon {{completion}} {{of this activity}} {{you will be able}} to: • describe the classical findings of cutaneous involvement by classical Mycobacterium tuberculosis. • list histologic features in skin biopsies that should raise suspicion of rapidly growing atypical <b>mycobacterial</b> <b>infections.</b> • list the special stains that are indicated in the workup of inflammatory conditions of the skin to assist in defining possible <b>mycobacterial</b> <b>infections.</b> <b>Mycobacterial</b> irifections of the skin classically cause a granulomatous tissue reaction. We have observed a suppurative pattern of inflammation associated with infections by rapid-growing Mycobacterium species in immunocompromised patients. We report 6 cases in skin and soft tissue wit...|$|R
5000|$|Isotuberculosinol, {{also called}} nosyberkol or edaxadiene is a {{diterpene}} molecule {{produced by the}} bacterium Mycobacterium tuberculosis, the causative agent of TB, which aids in its pathogenesis. Isotuberculosinol functions by preventing maturation of the host-cell phagosome in which the bacterium lives. Maturation of the phagosome would enable it to kill the bacterium. Mutations in genes involved in the biosynthetic pathway of nosyberkol result in normal development of the phagosome and reduction of <b>mycobacterial</b> <b>infection.</b> These biosynthetic genes include isotuberculosinol synthase.|$|E
50|$|Mycobacterium avium-intracellulare {{infection}} (MAI) is an atypical <b>mycobacterial</b> <b>infection,</b> i.e. {{one with}} nontuberculous mycobacteria or NTM, caused by Mycobacterium avium complex ("MAC"), {{which is made}} of three mycobacteria species, M. avium, M. intracellulare, and M. chimaera. This infection causes respiratory illness in birds, pigs, and humans, especially in immunocompromised people. In the later stages of AIDS {{it can be very}} severe. It usually first presents as a persistent cough. It is typically treated with a series of three antibiotics for a period of at least six months.|$|E
5000|$|Complicated silicosis: Silicosis {{can become}} [...] "complicated" [...] by the {{development}} of severe scarring (progressive massive fibrosis, or also known as conglomerate silicosis), where the small nodules gradually become confluent, reaching a size of 1 cm or greater. PMF is associated with more severe symptoms and respiratory impairment than simple disease. Silicosis can also be complicated by other lung disease, such as tuberculosis, non-tuberculous <b>mycobacterial</b> <b>infection,</b> and fungal infection, certain autoimmune diseases, and lung cancer. Complicated silicosis is more common with accelerated silicosis than with the chronic variety.|$|E
40|$|Sternal <b>mycobacterial</b> <b>infections</b> are rare. Due to the rarity, its {{clinical}} characteristics, diagnoses, {{and regular}} management strategies are still scanty. A total of 76 articles {{on this topic}} were obtained by a comprehensive literature collection. The clinical features, diagnosis, management strategies and prognosis were carefully analyzed. There were totally 159 patients including 152 (95 %) cases of tuberculosis (TB) and seven (5 %) cases of non-TB sternal <b>infections.</b> Sternal <b>mycobacterial</b> <b>infections</b> can be categorized into three types: Primary, secondary, and postoperative, according to the pathogenesis; and categorized into isolated, peristernal, and multifocal, according {{to the extent of}} the lesions. Microbiological investigation is more sensitive than medical imaging and Mantoux tuberculin skin test in the diagnosis of sternal infections. Most patients show good responses to the standard four-drug regimen and a surgical intervention was necessary in 28. 3 % patients. The prognoses of the patients are good with a very low mortality. A delayed diagnosis of sternal <b>mycobacterial</b> <b>infections</b> may bring about recurrent sternal infections and sustained incurability. An early diagnosis and prompt antibiotic regimens may significantly improve the patients' outcomes...|$|R
40|$|Leprosy is {{a chronic}} {{infectious}} disease caused by Mycobacterium leprae, a microorganism that usually affects skin and nerves. Although {{it is usually}} well-controlled by multidrug therapy (MDT), the disease may be aggravated by acute inflammatory reaction episodes that cause permanent tissue damage particularly to peripheral nerves. Tuberculosis is predominantly a disease of the lungs; however, it may spread to other organs and cause an extrapulmonary <b>infection.</b> Both <b>mycobacterial</b> <b>infections</b> are endemic in developing countries including Brazil, and cases of coinfection {{have been reported in}} the last decade. Nevertheless, simultaneous occurrence of perianal cutaneous tuberculosis and erythema nodosum leprosum is very rare, even in countries where both <b>mycobacterial</b> <b>infections</b> are endemic...|$|R
5000|$|Rifamycins are a {{subclass}} of ansamycins {{with high}} potency against mycobacteria. This resulted in their widespread {{use in the}} treatment of tuberculosis, leprosy, and AIDS-related <b>mycobacterial</b> <b>infections.</b> [...] Since then various analogues have been isolated from other prokaryotes.|$|R
